Chc Healthcare Group · TWSE:4164

Chc Healthcare — 2016 Institutional Investor Conference

32 slides from Chc Healthcare's conference presentation, Oct 20, 2016

1. Slide 1: 2016 Institutional Investor Conference

   2016 Institutional Investor Conference 4164 TT

2. Slide 2: Disclaimer

   Disclaimer • The information contained in this confidential document ("Presentation") has been prepared by CHC Healthcare Group (the "Company"). It has not been fully verified and is subject to material updating, revision and further amendment. • While the information contained herein has been prepa

3. Slide 3: Company Overview, Operational Results, Future Guidance, Q&A

   Company Operational Future Q&A Overview Results Guidance 3

4. Slide 4: Company Overview

   Company Operational Future Q&A Overview Results Guidance 4

5. Slide 5: Company Introduction

   Company Introduction • Name ： CHC Healthcare Group (4164 TT) • Date of Establish ： 2009/11/27 (First subsidiary, Chiu Ho Medical, was founded on 1977/08/12.) • Chairman ： Mr. Lee Pei-Lin • Headquarters ： Taipei • Branches ： Taichung, Kaohsiung, Beijing & Guangzhou • Major Business ： Providing Medica

6. Slide 6: Company Milestones

   Company Milestones 2016 • IBA first official direct 2014 selling contract signed in Taiwan 2012 • Greater China • Announce entering • Listed in TWSE Sole Distributor 2009 Taiwan’s long-term care Stock Exchange for Novadaq market on Oct 24, 2012 1999 • Founded CHC Healthcare Group • Install the first

7. Slide 7: Exclusive Distributor for Top Global Brands

   Exclusive Distributor for Top Global Brands Radiation Oncology Imaging System Ophthalmology & Neuroscience 7

8. Slide 8: Full Service Solution Provider "TurnKey Solutions"

   Full Service Solution Provider“TurnKey Solutions” Manufacturer Technical & Service Product Strength Strength Top Global Brands Manufacturers CHC Healthcare Group • Radiation Certified Service Team • Neuroscience Revenue Technical ．Site Planning Sharing Direct Selling • Ophthalmology Partnerships Ser

9. Slide 9: Product Mix

   Product Mix Service Revenue 13% Sales Revenue Revenue 50% Sharing 37% 2015 Annual Value-Added Business Model 9

10. Slide 10: Operational Results

    Company Operational Future Q&A Overview Results Guidance 10

11. Slide 11: Big Success in IBA Proton Therapy

    Big Success in IBA Proton Therapy CHC signed first official direct selling contract in Taiwan!!! 11

12. Slide 12: IBA Proton Therapy

    IBA Proton Therapy Unrivalled Experience 30+ 40+ 50,000+ 60%+ YEARS OF EXPERIENCE PARTNER INSTITUTIONS PATIENTS TREATED MARKET SHARE 12

13. Slide 13: Proton Design Flexibility

    Proton Design Flexibility ProteusPLUS ProteusONE 1,800m2 300 m2 13

14. Slide 14: IBA Proteus ONE

    14 iO 5 CHC HEALTHCARE GROUP

15. Slide 15: Pencil Beam Scanning by IBA

    Pencil Beam Scanning by IBA 15

16. Slide 16: Intra-Operative Imaging

    Intra-Operative Imaging SPY PINPOINT 16

17. Slide 17: Applications

    Applications • Coronary Artery Bypass Grafting(CABG) • Cardiovascular Surgery • Plastic Surgery • Reconstructive Surgery • Microsurgery • Organ Transplantation • Gastrointestinal Surgery 17

18. Slide 18: Elekta - Versa HD

    ©Elekta Elekta - Versa HD —— iO 5 CHC HEALTHCARE GROUP

19. Slide 19: High definition by high modulation

    High definition by high modulation • Precisely targeted • Intelligently controlled • Quality Assured 19

20. Slide 20: Corporate Governance

    Corporate Governance • 2015 Corporate Governance Evaluation – Ranking between top 21%~35% among all TWSE/TPEx listed companies • Corporate Social Responsibility Report (CSR Report) • – Will be published since 2016 CSR Committee 20

21. Slide 21: Future Guidance

    Company Operational Future Q&A Overview Results Guidance 21

22. Slide 22: Entering Long-Term Care Market

    Entering Long-Term Care Market 22

23. Slide 23: MoU Signed with Sakurajyuji Group

    MoU Signed with Sakurajyuji Group 2016．10 ．04 23

24. Slide 24: Sakurajyuji Group

    Sakurajyuji Group • Name ： Sakurajyuji Group • Date of Establish ： 2006/07 • CEO ： Mr. Tomoki Nishikawa • Number of employees ：About 2,100 people • Headquarters ： Kumamoto • Branches ： Kumamoto, Tokyo, Fukuoka, Yatsushiro, Singapore & Philippines • Major Business ： Running Hospital and Long-term Car

25. Slide 25: Elder-Friendly Design

    , =a a , me ee ee ee \ se a ee es , 2 a oe = on on peau co

26. Slide 26: Introduce New Product

    Introduce New Product 26

27. Slide 27: Elekta MR-Linac

    Elekta MR-Linac a GElekta

28. Slide 28: MR Adaptive RT

    MR Adaptive RT Soft Tissue Imaging with Diagnostic Quality + HD Dynamic Radiosurgery 28

29. Slide 29: Product Diversification

    Products and Geography Expansion Long-Term Care Business Cancer Center Consulting & Management New (Taiwan、China、Southeast Asia) Products Product Diversification IBA Proton Therapy Novadaq Fluorescence Imaging Technology (Greater China) White Essence Dental Clinic (Exclusive Greater China Distributo

30. Slide 30: Be the Leading Medical Equipment Full Service Solutions Provider in Asia-Pacific

    Headquarter in Subsidiary in Beijing Taiwan Subsidiary in Guangzhou Indonesia Be the Leading Medical Equipment Full Service Solutions Provider in Asia-Pacific 30

31. Slide 31: Company Overview, Operational Results, Future Guidance, Q&A

    Company Operational Future Overview Results Guidance Q&A 31

32. Slide 32: Thank you

    Thank you 32

CHC Healthcare Group — 2016 Institutional Investor Conference on 6ix